CAS: 457657-34-0
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | PA 452 REF: TR-P205818CAS: 457657-34-0 | - - - | 10,915.00 € | Tue 21 Jan 25 |
 | PA 452 REF: 3D-HTA65734CAS: 457657-34-0 | Min. 95% | To inquire | Wed 22 Jan 25 |
 | PA452 REF: TM-T16425CAS: 457657-34-0 | 96.76% | 91.00 €~1,266.00 € | Wed 12 Feb 25 |
PA 452
Controlled ProductCAS:457657-34-0
Formula:
C26H37N3O3
Color and Shape:
Neat
Molecular weight:
439.59
Ref: TR-P205818
| 50mg | 10,915.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
PA 452
CAS:457657-34-0
PA 452 is a synthetic analog of erythromycin, which has been shown to inhibit the …
Formula:
C26H37N3O3
Purity:
Min. 95%
Molecular weight:
439.59 g/mol
Ref: 3D-HTA65734
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Wednesday 22 Jan 2025
PA452
CAS:457657-34-0
PA452 is a selective antagonist of retinoic X receptor (RXR) and suppresses the effect of …
Formula:
C26H37N3O3
Purity:
96.76%
Color and Shape:
Solid
Molecular weight:
439.59
Ref: TM-T16425
| 1mg | 91.00 € | ||
| 5mg | 247.00 € | ||
| 10mg | 397.00 € | ||
| 25mg | 649.00 € | ||
| 50mg | 925.00 € | ||
| 100mg | 1,266.00 € | ||
| 1mL*10mM (DMSO) | 271.00 € |
Estimated delivery in United States, on Wednesday 12 Feb 2025
